Navigating nephrotoxicity: insights from 4 years of [177Lu]Lu-DOTA-TATE therapy at our institution

被引：0
|
作者：
Sousa, E. [1 ]
Sousa, R. [2 ]
Fraga, D. [1 ]
Carvalho, I. P. [1 ]
Vitorino, I. [1 ]
Rombo, D. [1 ]
Aco, J. [1 ]
Jorge, P. [1 ]
Salgado, L. [1 ]
机构：
[1] Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal
[2] Hosp Forcas Armadas, Lisbon, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
PRRT;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0591
引用
收藏
页码：S667 / S667
页数：1
相关论文
共 50 条
  • [1] Microfluidic synthesis of [177Lu]Lu-DOTA-TATE
    Liu, Zheng
    Schaap, Kevin
    Rohde, Martin
    Oehlke, Elisabeth
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S462 - S462
  • [2] Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE
    Prado-Wohlwend, S.
    Bernal-Vergara, J. C.
    Utrera-Costero, A.
    Canon-Sanchez, J. R.
    Agudelo-Cifuentes, M.
    Bello-Arques, P.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2022, 41 (01): : 55 - 65
  • [3] Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
    Sejin Ha
    Yong-il Kim
    Jungsu S. Oh
    Changhoon Yoo
    Baek-Yeol Ryoo
    Jin-Sook Ryu
    EJNMMI Physics, 11
  • [4] Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
    Ha, Sejin
    Kim, Yong-il
    Oh, Jungsu S.
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    Ryu, Jin-Sook
    EJNMMI PHYSICS, 2024, 11 (01)
  • [5] Re-treatment with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE of patients with progressive neuroendocrine neoplasm
    Durma, Adam Daniel
    Saracyn, Marek
    Kolodziej, Maciej
    Jozwik-Plebanek, Katarzyna
    Mroz, Adrianna
    Kapusta, Waldemar
    Dmochowska, Beata
    Kaminski, Grzegorz
    NUCLEAR MEDICINE REVIEW, 2023, 26 : 143 - 152
  • [6] Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours
    Geenen, Lorain
    Nonnekens, Julie
    Konijnenberg, Mark
    Baatout, Sarah
    De Jong, Marion
    Aerts, An
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 102 : 1 - 11
  • [7] Preventive measures and management of radiopharmaceutical extravasation with[177Lu]Lu-DOTA-TATE
    Eftychiou, N.
    Fernandez, R.
    Allen, S.
    Lewington, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S82 - S83
  • [8] Radiation exposure and protection advice after [177Lu]Lu-DOTA-TATE therapy in China
    Liu, Fei
    Li, Panli
    Xu, Junyan
    Zhang, Jianping
    Xu, Xiaoping
    Chen, Zhihao
    Qiao, Ying
    Liang, Yun
    Chen, Jie
    Song, Shaoli
    EJNMMI RESEARCH, 2024, 14 (01):
  • [9] A multivariate efficacy analysis of [177Lu]Lu-DOTA-TATE in the NETTER 2 study
    Pavel, M. E.
    Ferone, D.
    Halperin, D.
    Myrehaug, S.
    Herrmann, K.
    Kunz, P. L.
    Chasen, B.
    Castillon, J. Capdevila
    Tafuto, S.
    Oh, D-Y.
    Yoo, C.
    Falk, S.
    Halfdanarson, T. R.
    Folitar, I.
    Zhang, Y.
    de Herder, W. W.
    Singh, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S753 - S753
  • [10] Enhancing [177Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with chemotherapy
    Terry, S.
    Zink, J.
    O'Neill, E.
    Cornelissen, B.
    Nonnekens, J.
    Livieratos, L.
    Cheng, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S14 - S14
12345